Literature DB >> 35553631

Interferon-gamma and perforin-positive T cells in acquired aplastic anemia: implication in therapeutic response.

Vandana Sharma1, Prabin Kumar2, Rajiv Kumar3, Sushmita Chakraborty2, Manju Namdeo2, Sudha Sazawal1, Uma Kanga2, Tulika Seth1, Dipendra Kumar Mitra2.   

Abstract

Acquired aplastic anemia (aAA) is an autoimmune disease, characterized by infiltration of T lymphocytes in the bone marrow with destruction of hematopoietic stem cells by the effector cells. Interferon-gamma (IFN-γ) and perforin are important mediators of cell destruction. In this flow cytometry-based study, we have investigated the percentage of intracellular IFN-γ+ and perforin+ CD5+ T cells in peripheral blood of newly diagnosed aAA patients before and after immunosuppressive therapy (IST). Patients were categorized as per standard disease severity and response to IST. The median percentage of IFN-γ+ and perforin+ CD5+ T cells was higher in untreated patients compared to healthy controls. The percentage of these cells was also increased in untreated severe and very severe aplastic anemia when compared with non-severe aplastic anemia patients. In patients before and after IST the median percentage of T cells producing IFN-γ and perforin was elevated in non-responders as compared to partial plus complete responders. The higher percentage of IFN-γ+ and perforin+ CD5+ T cells may be useful as an early diagnostic marker for aberrant activation of immune system and predict poor response to IST in aAA patients, who will benefit from alternative therapy.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  T cells; acquired aplastic anemia; immunosuppressive therapy; interferon-gamma; perforin

Mesh:

Substances:

Year:  2022        PMID: 35553631      PMCID: PMC9113177          DOI: 10.1093/cei/uxab006

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

Authors:  B M Camitta; E D Thomas; D G Nathan; G Santos; E C Gordon-Smith; R P Gale; J M Rappeport; R Storb
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

2.  Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia.

Authors:  C Dufour; A Corcione; J Svahn; R Haupt; N Battilana; V Pistoia
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

3.  Methodology to understand how perforin assembles on membranes.

Authors:  S Ghorbian; M Abkar; A Poursadegh Zonouzi
Journal:  Scand J Immunol       Date:  2014-07       Impact factor: 3.487

Review 4.  How I treat acquired aplastic anemia.

Authors:  Andrea Bacigalupo
Journal:  Blood       Date:  2017-01-17       Impact factor: 22.113

5.  Circulating activated suppressor T lymphocytes in aplastic anemia.

Authors:  N C Zoumbos; P Gascón; J Y Djeu; S R Trost; N S Young
Journal:  N Engl J Med       Date:  1985-01-31       Impact factor: 91.245

6.  Type I and type II T-cell profiles in aplastic anemia and refractory anemia.

Authors:  H Tsuda; H Yamasaki
Journal:  Am J Hematol       Date:  2000-08       Impact factor: 10.047

7.  Perforin gene mutations in patients with acquired aplastic anemia.

Authors:  Elena E Solomou; Federica Gibellini; Brian Stewart; Daniela Malide; Maria Berg; Valeria Visconte; Spencer Green; Richard Childs; Stephen J Chanock; Neal S Young
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

8.  Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.

Authors:  Elaine Sloand; Sonnie Kim; Jaroslaw P Maciejewski; John Tisdale; Dean Follmann; Neal S Young
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 9.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

10.  Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers.

Authors:  Weihua Zeng; Guibin Chen; Sachiko Kajigaya; Olga Nunez; Alexandra Charrow; Eric M Billings; Neal S Young
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.